How were the Tenon Medical (TNON) shares related to SiVantage, Inc. issued?

Tenon Medical issued 276,228 common shares to SiVantage, Inc. on May 1, 2026 under an Asset Purchase Agreement dated August 1, 2025. The issuance occurred upon achievement of a specified milestone described in that agreement as non-market consideration.

Does Wyatt D. Geist claim full beneficial ownership of the SiVantage Tenon Medical (TNON) shares?

No. Wyatt D. Geist explicitly disclaims beneficial ownership of Tenon Medical shares held by SiVantage, Inc. except to the extent of his pecuniary interest. That interest is based on his 49.38% equity ownership in SiVantage, which holds the issued shares.

Tenon Medical (TNON) officer reports indirect stock grant via SiVantage

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Geist Wyatt D. reported acquisition or exercise transactions in this Form 4 filing.

Tenon Medical, Inc. disclosed that on May 1, 2026 it issued 276,228 shares of common stock to SiVantage, Inc. under an Asset Purchase Agreement tied to a milestone achievement. Chief Innovation Officer Wyatt D. Geist has a 49.38% equity interest in SiVantage, giving him an indirect pecuniary interest in 136,401 of these shares, increasing his indirect holdings to 487,166 shares held by SiVantage. He also holds 157,569 shares directly and disclaims beneficial ownership of SiVantage’s shares except to the extent of his pecuniary interest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Geist Wyatt D.

Role Chief Innovation Officer

Type	Security	Shares	Price	Value
Grant/Award	Common stock	136,401	$0.00	--
holding	Common stock	--	--	--

Holdings After Transaction: Common stock — 487,166 shares (Indirect, By SiVantage, Inc.); Common stock — 157,569 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares issued to SiVantage: 276,228 shares Indirectly acquired shares: 136,401 shares Indirect holdings after transaction: 487,166 shares +3 more

6 metrics

Shares issued to SiVantage 276,228 shares Common stock issued on May 1, 2026 under Asset Purchase Agreement milestone

Indirectly acquired shares 136,401 shares Wyatt D. Geist’s indirect pecuniary interest reported in Form 4

Indirect holdings after transaction 487,166 shares Total Tenon Medical shares held by SiVantage reflecting Geist’s pecuniary interest

Direct holdings 157,569 shares Tenon Medical common stock held directly by Wyatt D. Geist

Equity interest in SiVantage 49.38% Geist’s ownership stake in SiVantage determining his pecuniary interest

Share price per reported acquisition $0.00 per share Non-cash acquisition of 136,401 Tenon Medical shares attributed to Geist

Key Terms

Asset Purchase Agreement, indirect pecuniary interest, disclaims beneficial ownership, milestone

4 terms

Asset Purchase Agreement financial

"pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage"

An asset purchase agreement is a legal contract in which a buyer agrees to buy specific assets and contracts of a business rather than buying the company’s stock or ownership. It matters to investors because it determines exactly what is being bought and what liabilities stay behind — like buying the furniture and equipment from a store but not the building or past debts — which affects the deal’s value, taxes and future risk exposure.

indirect pecuniary interest financial

"represent the reporting person's indirect pecuniary interest in the shares held by SiVantage"

disclaims beneficial ownership regulatory

"The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest"

milestone financial

"in connection with the achievement of a certain milestone set forth therein"

Form 4 Insider Transactions: What Each Field Means →

05/05/2026 - 07:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geist Wyatt D.

(Last)

(First)

(Middle)

104 COOPER CT.

(Street)

LOS GATOS

CALIFORNIA

95032

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Innovation Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	05/01/2026		A		136,401	A	$0	487,166	I	By SiVantage, Inc.⁽¹⁾
Common stock								157,569	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 49.38% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

	/s/ Wyatt Geist	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Tenon Medical (TNON) report for Wyatt D. Geist?

Tenon Medical reported that Wyatt D. Geist gained an indirect pecuniary interest in 136,401 common shares on May 1, 2026. These shares were issued to SiVantage, Inc. after a milestone under an Asset Purchase Agreement, not through an open-market trade.

What is Wyatt D. Geist’s indirect holding in Tenon Medical (TNON) after this filing?

Following the May 1, 2026 transaction, Wyatt D. Geist’s indirect pecuniary interest in Tenon Medical totals 487,166 common shares held by SiVantage, Inc. This reflects his 49.38% equity stake in SiVantage and the newly issued milestone shares.

How many Tenon Medical (TNON) shares does Wyatt D. Geist hold directly?

The Form 4 shows Wyatt D. Geist directly holding 157,569 Tenon Medical common shares. This direct position is separate from his indirect pecuniary interest in shares held by SiVantage, Inc., where he owns a partial equity stake.

Was cash paid for the Tenon Medical (TNON) shares reported in this Form 4?

The reported acquisition of 136,401 Tenon Medical shares for Wyatt D. Geist shows a per-share price of $0.00. The shares were issued to SiVantage, Inc. as milestone consideration under an Asset Purchase Agreement, rather than bought in the market.